Chen Benafsha
Overview
Explore the profile of Chen Benafsha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amar-Lewis E, Cohen L, Chintakunta R, Benafsha C, Lavi Y, Goldbart R, et al.
Small
. 2024 Oct;
20(51):e2405524.
PMID: 39359045
Starch-based nanoparticles are highly utilized in the realm of drug delivery taking advantage of their biocompatibility and biodegradability. Studies have utilized Quaternized starch (Q-starch) for small interfering RNA (siRNA) delivery,...
2.
Blitsman Y, Hollander E, Benafsha C, Yegodayev K, Hadad U, Goldbart R, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38339058
Given the role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in modulating cellular processes such as proliferation, survival, and migration, we hypothesized its potential as a novel therapeutic agent for wound closure enhancement....
3.
Novoplansky O, Shnerb A, Marripati D, Jagadeeshan S, Shareb R, Conde-Lopez C, et al.
Mol Oncol
. 2023 Jul;
17(12):2618-2636.
PMID: 37501404
Blocking the mitogen-activated protein kinase (MAPK) pathway with the MEK1/2 inhibitor trametinib has produced promising results in patients with head and neck squamous cell carcinoma (HNSCC). In the current study,...
4.
Blitsman Y, Benafsha C, Yarza N, Zorea J, Goldbart R, Traitel T, et al.
Nanomaterials (Basel)
. 2023 Jul;
13(13).
PMID: 37446506
The tailored design of drug delivery systems for specific therapeutic agents is a prevailing approach in the field. In this paper, we present a study that highlights the potential of...